C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/49 (2006.01) A61K 39/21 (2006.01) C07K 14/16 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2068713
2068713 9107425 PCTABS00005 Nonreplicating recombinant-made retroviral particles having structural, morphological and immunological characteristics very similar to those of native human retroviruses are described. The method of the invention involves coexpression of mature retroviral core and envelope structural proteins in mammalian host cells such that the expressed retroviral proteins associate into assembled budding retroviral particles. In a particular embodiment of the invention, nonreplicating recombinant-made HIV-1 particles are produced by coinfecting mammalian host cells with a recombinant vaccinia virus carrying the Human Immunodeficiency Virus Type 1 (HIV-1) gag and protease genes and a recombinant vaccinia virus carrying the HIV-1 env gene. These nonreplicating recombinant-made HIV-1 particles have immunological and morphological characteristics closely resembling those of native HIV-1, are able to block the infectivity of live HIV in vitro, and are highly immunogenic in vivo. The recombinant-made HIV-1 particles of the invention may be used as anti-viral agents and as immunogens in vaccine formulations effective at inhibiting or preventing infection by HIV and/or the development of the Acquired Immunodeficiency Syndrome.
Haffar Omar K.
Hu Shiu-Lok
Senear Allen W.
Travis Bruce M.
LandOfFree
Non-replicating recombinant-made retroviral particles used... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-replicating recombinant-made retroviral particles used..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-replicating recombinant-made retroviral particles used... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2088629